Objectives: Cytology and histology are 2 indispensable diagnostic tools for cancer diagnosis, which are rapidly increasing in importance with aging populations. We applied mass spectrometry (MS) as a rapid approach for swiftly acquiring nonmorphological information of interested cells. Conventional MS, which primarily rely on promoting ionization by pre-applying a matrix to cells, has the drawback of time-consuming both on data acquisition and analysis. As an emerging method, probe electrospray ionization-MS (PESI-MS) with a dedicated probe is capable to pierce sample and measure specimen in small amounts, either liquid or solid, without the requirement for sample pretreatment. Furthermore, PESI-MS is timesaving compared to the conventional MS. Herein, we investigated the capability of PESI-MS to characterize the cell types derived from the respiratory tract of human tissues. Study Design: PESI-MS analyses with DPiMS-2020 were performed on various type of cultured cells including 5 lung squamous cell carcinomas, 5 lung adenocarcinomas, 5 small-cell carcinomas, 4 malignant mesotheliomas, and 2 normal controls. Results: Several characteristic peaks were detected at around m/z 200 and 800 that were common in all samples. As expected, partial least squares-discriminant analysis of PESI-MS data distinguished the cancer cell types from normal control cells. Moreover, distinct clusters divided squamous cell carcinoma from adenocarcinoma. Conclusion: PESI-MS presented a promising potential as a novel diagnostic modality for swiftly acquiring specific cytological information.

1.
Bizzini
A
,
Durussel
C
,
Bille
J
,
Greub
G
,
Prod’hom
G
.
Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory
.
J Clin Microbiol
.
2010 May
;
48
(
5
):
1549
54
. .
2.
Jia
Z
,
Zhang
H
,
Ong
CN
,
Patra
A
,
Lu
Y
,
Lim
CT
,
Detection of lung cancer: concomitant volatile organic compounds and metabolomic profiling of six cancer cell lines of different histological origins
.
ACS Omega
.
2018 May 31
;
3
(
5
):
5131
40
. .
3.
Huang
H
,
Tong
TT
,
Yau
L-F
,
Chen
C-Y
,
Mi
J-N
,
Wang
JR
,
LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain
.
BMC Cancer
.
2018
;
18
:
799
. .
4.
Alazzo
A
,
Al-Natour
MA
,
Spriggs
K
,
Stolnik
S
,
Ghaemmaghami
A
,
Kim
DH
,
Investigating the intracellular effects of hyperbranched polycation-DNA complexes on lung cancer cells using LC-MS-based metabolite profiling
.
Mol Omics
.
2019 Feb 11
;
15
(
1
):
77
87
. .
5.
Lim
SL
,
Jia
Z
,
Lu
Y
,
Zhang
H
,
Ng
CT
,
Bay
BH
,
Metabolic signatures of four major histological types of lung cancer cells
.
Metabolomics
.
2018 Aug 31
;
14
(
9
):
118
. .
6.
Li
W
,
Zhang
W
,
Deng
W
,
Zhong
Y
,
Zhang
Y
,
Peng
Z
,
Quantitative proteomic analysis of mitochondrial proteins differentially expressed between small cell lung cancer cells and normal human bronchial epithelial cells
.
Thorac Cancer
.
2018 Nov
;
9
(
11
):
1366
75
. .
7.
Sappington
D
,
Helms
S
,
Siegel
E
,
Penney
RB
,
Jeffus
S
,
Bartter
T
,
Diagnosis of lung tumor types based on metabolomic profiles in lymph node aspirates
.
Cancer Treat Res Commun
.
2018
;
14
:
1
6
. .
8.
Kriegsmann
K
,
Longuespée
R
,
Hundemer
M
,
Zgorzelski
C
,
Casadonte
R
,
Schwamborn
K
,
Combined immunohistochemistry after mass spectrometry imaging for superior spatial information
.
Proteomics Clin Appl
.
2019 Jan
;
13
(
1
):
e1800035
. .
9.
Berghmans
E
,
Van Raemdonck
G
,
Schildermans
K
,
Willems
H
,
Boonen
K
,
Maes
E
,
MALDI mass spectrometry imaging linked with top-down proteomics as a tool to study the non-small-cell lung cancer tumor microenvironment
.
Methods Protoc
.
2019 May 28
;
2
(
2
):
44
. .
10.
Yoshimura
K
,
Chen
LC
,
Yu
Z
,
Hiraoka
K
,
Takeda
S
.
Real-time analysis of living animals by electrospray ionization mass spectrometry
.
Anal Biochem
.
2011 Oct 15
;
417
(
2
):
195
201
. .
11.
Yoshimura
K
,
Mandal
MK
,
Hara
M
,
Fujii
H
,
Chen
LC
,
Tanabe
K
,
Real-time diagnosis of chemically induced hepatocellular carcinoma using a novel mass spectrometry-based technique
.
Anal Biochem
.
2013 Oct 1
;
441
(
1
):
32
7
. .
12.
Yoshimura
K
,
Chen
LC
,
Mandal
MK
,
Nakazawa
T
,
Yu
Z
,
Uchiyama
T
,
Analysis of renal cell carcinoma as a first step for developing mass spectrometry-based diagnostics
.
J Am Soc Mass Spectrom
.
2012 Oct
;
23
(
10
):
1741
9
. .
13.
Ashizawa
K
,
Yoshimura
K
,
Johno
H
,
Inoue
T
,
Katoh
R
,
Funayama
S
,
Construction of mass spectra database and diagnosis algorithm for head and neck squamous cell carcinoma
.
Oral Oncol
.
2017 Dec
;
75
:
111
9
. .
14.
Iwano
T
,
Yoshimura
K
,
Inoue
S
,
Odate
T
,
Ogata
K
,
Funatsu
S
,
Breast cancer diagnosis based on lipid profiling by probe electrospray ionization mass spectrometry
.
Br J Surg
.
2020 May
;
107
(
6
):
632
5
. .
15.
Giordano
S
,
Takeda
S
,
Donadon
M
,
Saiki
H
,
Brunelli
L
,
Pastorelli
R
,
Rapid automated diagnosis of primary hepatic tumour by mass spectrometry and artificial intelligence
.
Liver Int
.
2020 Dec
;
40
(
12
):
3117
24
. .
16.
Coudray
N
,
Ocampo
PS
,
Sakellaropoulos
T
,
Narula
N
,
Snuderl
M
,
Fenyö
D
,
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
.
Nat Med
.
2018 Oct
;
24
(
10
):
1559
67
. .
17.
Sakamoto
K
,
Fujita
Y
,
Chikamatsu
K
,
Tanaka
S
,
Takeda
S
,
Masuyama
K
,
Ambient mass spectrometry-based detection system for tumor cells in human blood
.
Transl Cancer Res
.
2018
;
7
(
3
):
758
64
. .
18.
Baram
D
,
Garcia
RB
,
Richman
PS
.
Impact of rapid on-site cytologic evaluation during transbronchial needle aspiration
.
Chest
.
2005 Aug
;
128
(
2
):
869
75
. .
19.
Chen
F
,
Lin
L
,
Zhang
J
,
He
Z
,
Uchiyama
K
,
Lin
JM
.
Single-cell analysis using drop-on-demand inkjet printing and probe electrospray ionization mass spectrometry
.
Anal Chem
.
2016 Apr 19
;
88
(
8
):
4354
60
. .
20.
Behrmann
J
,
Etmann
C
,
Boskamp
T
,
Casadonte
R
,
Kriegsmann
J
,
Maaß
P
.
Deep learning for tumor classification in imaging mass spectrometry
.
Bioinformatics
.
2018 Apr 1
;
34
(
7
):
1215
23
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.